Search

everythinglearnresearchcommunity

for

Search:↓

Ethinylestradiol/Chlormadinone Acetate is a safe and effective birth control pill that also helps regulate menstrual cycles, reduces period pain, and treats certain skin and hair conditions.

Finasteride improves hair growth and satisfaction in men with male pattern baldness but may cause sexual side effects.

Finasteride helps increase or maintain hair in most men but can cause sexual side effects and should not be used by women, especially during pregnancy.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

The new clinical trial design is promising but needs real-world trials to test its effectiveness and possible enhancements.

Ustekinumab significantly improved sexual function and quality of life for people with moderate to severe psoriasis.

Dutasteride 0.5 mg daily improves hair growth safely in men with hair loss.

Neoadjuvant chemotherapy followed by surgery leads to fewer severe complications and better quality of life than immediate surgery in advanced ovarian cancer patients with high tumor load.

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.

Topical finasteride is an effective and safer treatment for male hair loss.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Hair regrowth from severe alopecia areata treatment with baricitinib can vary, with faster results in those with shorter hair loss duration.

The new 5% minoxidil foam is as effective and safe as Rogaine® for treating hair loss in Chinese men.

The oral contraceptive with ethinyl estradiol and chlormadinone acetate is effective in treating moderate acne.

Oral paclitaxel plus encequidar improved tumor response and caused less neuropathy but more serious infections than intravenous paclitaxel.

Pegylated liposomal doxorubicin is as effective as conventional doxorubicin but causes fewer heart problems and side effects.

Temozolomide improves survival in grade III glioma patients without harming quality of life.

Orphan drug benefit scores in Germany are influenced by phase III data and lack of alternatives, but not linked to price or discounts.

DHL-HisZnNa may help reduce hair loss from chemotherapy, but more research is needed.

Topical finasteride might help with male hair loss with fewer side effects than pills, but more research is needed.

Baricitinib improves quality of life and reduces anxiety and depression in severe alopecia areata patients with hair regrowth.

The document concludes that various treatments for skin conditions are effective, but some require further research, and certain factors like gender and lifestyle can influence disease outcomes.

PLD is an effective and safer alternative for treating breast cancer.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

Liposomal anthracyclines are effective and safer for treating multiple myeloma, especially in elderly patients.

Many potential alopecia treatments need more testing to confirm they promote acceptable hair growth with minimal side effects.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

Topical JAK inhibitors may help treat some skin conditions but need more research.